)
)
Acarix Investor Relations Material
Latest events
Q3 2024
Acarix
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Acarix
Access all reports
Acarix AB is a Swedish medical technology company specializing in diagnostic solutions for coronary artery disease (CAD). Its flagship product, the CADScor System, uses sensitive acoustics and advanced algorithms to assess coronary blood flow, providing a rapid, non-invasive method for ruling out CAD in patients experiencing chest pain. The system is designed for use in clinical settings by healthcare professionals to help streamline the diagnosis process. The company is headquartered in Malmö, Sweden, and its shares are traded on the Nasdaq Stockholm.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
ACARIX
Country
🇸🇪 Sweden